Isotonitazene
|
Isotonitazene
N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine |
|
| N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine | |
| Nitazenes | |
| Synthetic opioids |
|
| 14188-81-9 | |
|
|
InChI=1S/C23H30N4O3/c1-5-25(6-2)13-14-26-22-12-9-19(27(28)29)16-21(22)24-23(26)15-18-7-10-20(11-8-18)30-17(3)4/h7-12,16-17H,5-6,13-15H2,1-4H3
|
|
OIOQREYBGDAYGT-UHFFFAOYSA-N
|
|
|
O=[N+](C1=CC=C2C(N=C(CC3=CC=C(OC(C)C)C=C3)N2CCN(CC)CC)=C1)[O-]
|
|
| C23H30N4O3 | |
| 410.5093 g/mol | |
| 61/I | |
| 2021 | |
|
This substance is included in Schedule I of the 1961 Single Convention on Narcotic Drugs.
|